PON1 and Huntington disease: Similarly, intravenous administration of vitamin C in HD patients for 6 months exerted a beneficial effect, with an increase in antioxidant defense evaluated by PON1 activity, and a decrease in oxidative stress markers (lipid hydroperoxides and AGE adducts) compared to non-supplemented HD patients [83].